Annual EBIT
-$88.73 M
-$30.65 M-52.77%
December 31, 2023
Summary
- As of February 8, 2025, CARM annual earnings before interest & taxes is -$88.73 million, with the most recent change of -$30.65 million (-52.77%) on December 31, 2023.
- During the last 3 years, CARM annual EBIT has fallen by -$60.35 million (-212.68%).
- CARM annual EBIT is now -212.68% below its all-time high of -$28.38 million, reached on December 1, 2020.
Performance
CARM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$13.14 M
-$1.47 M-12.63%
September 30, 2024
Summary
- As of February 8, 2025, CARM quarterly earnings before interest & taxes is -$13.14 million, with the most recent change of -$1.47 million (-12.63%) on September 30, 2024.
- Over the past year, CARM quarterly EBIT has increased by +$9.20 million (+41.17%).
- CARM quarterly EBIT is now -29.42% below its all-time high of -$10.16 million, reached on March 1, 2022.
Performance
CARM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$66.77 M
+$9.20 M+12.11%
September 30, 2024
Summary
- As of February 8, 2025, CARM TTM earnings before interest & taxes is -$66.77 million, with the most recent change of +$9.20 million (+12.11%) on September 30, 2024.
- Over the past year, CARM TTM EBIT has increased by +$16.75 million (+20.05%).
- CARM TTM EBIT is now -557.48% below its all-time high of -$10.16 million, reached on March 1, 2022.
Performance
CARM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CARM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.8% | +41.2% | +20.1% |
| 3 y3 years | -212.7% | +23.8% | -15.0% |
| 5 y5 years | -212.7% | +23.8% | -15.0% |
CARM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -117.5% | at low | -29.4% | +42.8% | -557.5% | +24.8% |
| 5 y | 5-year | -212.7% | at low | -29.4% | +42.8% | -557.5% | +24.8% |
| alltime | all time | -212.7% | at low | -29.4% | +42.8% | -557.5% | +24.8% |
Carisma Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.14 M(+12.6%) | -$66.77 M(-12.1%) |
| Jun 2024 | - | -$11.67 M(-40.2%) | -$75.97 M(-10.9%) |
| Mar 2024 | - | -$19.51 M(-13.1%) | -$85.27 M(-3.9%) |
| Dec 2023 | -$88.73 M | -$22.45 M(+0.5%) | -$88.73 M(+6.2%) |
| Sep 2023 | - | -$22.34 M(+6.6%) | -$83.52 M(+7.2%) |
| Jun 2023 | - | -$20.96 M(-8.7%) | -$77.93 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$22.97 M(+33.2%) | -$70.90 M(+22.1%) |
| Dec 2022 | -$58.08 M(+42.4%) | -$17.24 M(+2.9%) | -$58.08 M(+42.2%) |
| Sep 2022 | - | -$16.75 M(+20.2%) | -$40.84 M(+69.5%) |
| Jun 2022 | - | -$13.93 M(+37.2%) | -$24.09 M(+137.2%) |
| Mar 2022 | - | -$10.16 M | -$10.16 M |
| Dec 2021 | -$40.79 M(+43.8%) | - | - |
| Dec 2020 | -$28.38 M | - | - |
FAQ
- What is Carisma Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Carisma Therapeutics?
- What is Carisma Therapeutics annual EBIT year-on-year change?
- What is Carisma Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Carisma Therapeutics?
- What is Carisma Therapeutics quarterly EBIT year-on-year change?
- What is Carisma Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Carisma Therapeutics?
- What is Carisma Therapeutics TTM EBIT year-on-year change?
What is Carisma Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CARM is -$88.73 M
What is the all time high annual EBIT for Carisma Therapeutics?
Carisma Therapeutics all-time high annual earnings before interest & taxes is -$28.38 M
What is Carisma Therapeutics annual EBIT year-on-year change?
Over the past year, CARM annual earnings before interest & taxes has changed by -$30.65 M (-52.77%)
What is Carisma Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CARM is -$13.14 M
What is the all time high quarterly EBIT for Carisma Therapeutics?
Carisma Therapeutics all-time high quarterly earnings before interest & taxes is -$10.16 M
What is Carisma Therapeutics quarterly EBIT year-on-year change?
Over the past year, CARM quarterly earnings before interest & taxes has changed by +$9.20 M (+41.17%)
What is Carisma Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CARM is -$66.77 M
What is the all time high TTM EBIT for Carisma Therapeutics?
Carisma Therapeutics all-time high TTM earnings before interest & taxes is -$10.16 M
What is Carisma Therapeutics TTM EBIT year-on-year change?
Over the past year, CARM TTM earnings before interest & taxes has changed by +$16.75 M (+20.05%)